Search Within

Jessie Bourcier

Formats
  1. Meeting Abstract (5)
  2. Journal Article (3)
  3. Editorial (1)
  4. Research Letter (1)
Groups
  1. Center for Hematologic Malignancies (10)
  2. Department of Medicine (10)
  3. Executive Committee, Center for Hematologic Malignancies (10)
  4. GSK Faculty (10)
  5. Hematologic Malignancies, Division of (10)
  6. Sloan Kettering Institute Postdocs (10)

More Groups

People
  1. Omar Abdel-Wahab (10)
  2. Simon Hogg (6)
  3. Sydney Lu (4)
  4. Xiaoli Mi (4)
  5. Andrew Zelenetz (3)
  6. Anthony Mato (3)

More People

Years
  1. 2024 (2)
  2. 2023 (3)
  3. 2022 (5)
Publications
  1. Blood (3)
  2. Blood Cancer Discovery (1)
  3. Cancer Cell (1)
  4. Cancer Science (1)
  5. Hematological Oncology (1)
  6. Leukemia (1)

More Publications

Publishers
  1. American Society of Hematology (3)
  2. Wiley Blackwell (2)
  3. American Association for Cancer Research (1)
  4. American Association for the Advancement of Science (1)
  5. Cell Press (1)
  6. Massachusetts Medical Society (1)

More Publishers

Results (10)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Altered RNA splicing and AML therapy resistance
    Meeting Abstract

    Wang, E.; Pineda, J.; Kim, W.; Chen, S.; Bourcier, J.; Stahl, M.; Hogg, S.; Knorr, K.; Stanley, R.; Bradley, R.; more...
    Cancer Science (2024)

    Fulltext@MSK | Save
  • Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127
    Journal Article

    Montoya, S.; Bourcier, J.; Noviski, M.; Lu, H.; Thompson, M. C.; Chirino, A.; Jahn, J.; Sondhi, A. K.; Gajewski, S.; Tan, Y. S.; more...
    Science (2024)

    Fulltext@MSK | Save
  • E7820, an anti-cancer sulfonamide, degrades RBM39 in patients with splicing factor mutant myeloid malignancies: A phase II clinical trial
    Research Letter

    Bewersdorf, J. P.; Stahl, M.; Taylor, J.; Mi, X.; Chandhok, N. S.; Watts, J.; Derkach, A.; Wysocki, M.; Lu, S. X.; Bourcier, J.; more...
    Leukemia (2023)

    Fulltext@MSK | Save
  • Drug‐resistance mutations in BTK occur in distinct enzymatic classes and are overcome by BTK degradation
    Meeting Abstract

    Montoya, S.; Bourcie, J.; Sondhi, A.; Jahn, J.; Alencar, A.; Abdel-Wahab, O.; Taylor, J.
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Modulation of RNA splicing enhances response to BCL2 inhibition in leukemia
    Journal Article

    Wang, E.; Pineda, J. M. B.; Kim, W. J.; Chen, S.; Bourcier, J.; Stahl, M.; Hogg, S. J.; Bewersdorf, J. P.; Han, C.; Singer, M. E.; more...
    Cancer Cell (2023)

    Fulltext@MSK | Save
  • A phase II clinical trial of E7820 for patients with relapsed/refractory myeloid malignancies with mutations in splicing factor genes
    Meeting Abstract

    Bewersdorf, J. P.; Stahl, M. F.; Taylor, J.; Chandhok, N. S.; Watts, J.; Derkach, A.; Wysocki, M.; Kostantakis, V.; Lu, S. X.; Bourcier, J.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Kinase dead BTK mutations confer resistance to covalent and noncovalent BTK inhibitors but are susceptible to clinical stage BTK degraders
    Meeting Abstract

    Montoya, S.; Bourcier, J.; Thompson, M. C.; Noviski, M.; Tan, M.; Wang, E.; Mi, X.; Brathaban, N.; Risso, C. B.; Tsai, D.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Attenuation of graft-versus-host-disease via genetic or pharmacologic inhibition of the RNA splicing factor RBM39
    Meeting Abstract

    Bourcier, J.; Hogg, S. J.; Erickson, C.; Singer, M. E.; Tittley, S.; Ito, T.; Egorova, A.; Kuttiyara, J.; Hanash, A. M.; Abdel-Wahab, O.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Splicing-mediated antigen escape from immunotherapy for B-cell malignancies
    Editorial

    Bourcier, J.; Abdel-Wahab, O.
    Blood Cancer Discovery (2022)

    Fulltext@MSK | Save
  • Mechanisms of resistance to noncovalent Bruton's tyrosine kinase inhibitors
    Journal Article

    Wang, E.; Mi, X.; Thompson, M. C.; Montoya, S.; Notti, R. Q.; Afaghani, J.; Durham, B. H.; Penson, A.; Witkowski, M. T.; Lu, S. X.; more...
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save